Exhibit 10.2
PEDIATRIX MEDICAL GROUP
AMENDED AND RESTATED CREDIT AGREEMENT
Originally Dated as of June 27, 1996
As Amended and Restated as of November 1, 2000
As Amended and Restated as of August 14, 2001
CONSENT AND AMENDMENT NO. 5
Dated as of May 13, 2003
FLEET NATIONAL BANK, Agent and Lender
U.s. bank national association, Syndication Agent and Lender
HSBC BANK USA, Documentation Agent and Lender
CONSENT AND AMENDMENT NO. 5
TO AMENDED AND RESTATED CREDIT AGREEMENT
This agreement, dated as of May 13, 2003 (this "CONSENT AND AMENDMENT"), is
among Pediatrix Medical Group, Inc., a Florida corporation, the Material Related
Entities of Pediatrix Medical Group, Inc. from time to time party hereto, and
the Lenders from time to time party hereto including Fleet National Bank, both
in its capacity as a Lender and in its capacity as an Agent, U.S. Bank National
Association, formerly known as Firstar Bank N.A., both in its capacity as a
Lender and in its capacity as Syndication Agent, and HSBC Bank USA, both in its
capacity as a Lender and in its capacity as Documentation Agent. The parties
agree as follows:
CREDIT AGREEMENT; DEFINITIONS. This Consent and Amendment is granted in
connection with and amends the Credit Agreement originally dated as of June 27,
1996, as amended and restated as of November 1, 2000 and as further amended and
restated as of August 14, 2001 among the parties hereto (as in effect prior to
giving effect to this Consent and Amendment, the "CREDIT AGREEMENT"). Terms
defined in the Credit Agreement as amended hereby (the "AMENDED CREDIT
AGREEMENT") and not otherwise defined herein are used with the meaning so
defined.
CONSENT. The Company has stated its desire to acquire, through a wholly-owned
subsidiary, 100% of the capital stock of Neo Gen Screening, Inc., a Pennsylvania
corporation (the "Corporation"), and 100% of the outstanding partnership
interests of Neo Gen Screening, L.P., a Pennsylvania limited partnership (the
"Partnership", and together with the Corporation, "Neo Gen Screening"), pursuant
to a Letter of Intent dated May 2, 2003, copies of which have been forwarded to
each of the Lenders (the "Neo Gen Acquisition"). Notwithstanding the
requirements of Section 6.9.4 of the Credit Agreement, the Required Lenders
hereby consent to the Neo Gen Acquisition for a total Purchase Price that shall
not exceed $34 million of cash consideration.
AMENDMENT OF CREDIT AGREEMENT. Effective upon the date all the conditions set
forth in Section 5 hereof are satisfied (the "AMENDMENT DATE"), which conditions
must be satisfied no later than the date provided therein, the Credit Agreement
is amended as follows:
AMENDMENT OF SECTION 6.2.1. Section 6.2.1 of the Credit Agreement is amended to
read in its entirety as follows:
"6.2.1 TYPES OF BUSINESS. The Borrowers shall engage only in
the business of (a) pediatric, neonatal and perinatal services and
related services; and (b) screening newborns and young children for
genetic disorders."
REPRESENTATIONS AND WARRANTIES. Each of the Obligors jointly and severally
represents and warrants as follows: LEGAL EXISTENCE, ORGANIZATION. Each of the
Obligors is duly organized and validly existing and in good standing under the
laws of the jurisdiction of its organization, with all power and authority,
corporate, limited liability company, partnership or otherwise, necessary (a) to
enter into and perform this Consent and Amendment and the Amended Credit
Agreement and (b) to own its properties and carry on the business now conducted
or proposed to be conducted by it. Each of the Obligors has taken all corporate,
limited liability company, partnership or other action required to make the
provisions of this Consent and Amendment and the Amended Credit Agreement the
valid and enforceable obligations they purport to be.
ENFORCEABILITY. Each of the Obligors has duly authorized, executed and delivered
this Consent and Amendment. Each of this Consent and Amendment and the Amended
Credit Agreement is the legal, valid and binding obligation of each of the
Obligors and is enforceable against the Obligors in accordance with its terms.
NO LEGAL OBSTACLE TO AGREEMENTS. Neither the execution, delivery or performance
of this Consent and Amendment, nor the performance of the Amended Credit
Agreement, nor the consummation of any other transaction referred to or
contemplated by this Consent and Amendment, nor the fulfillment of the terms
hereof or thereof, has constituted or resulted in or will constitute or result
in:
any breach or termination of any agreement, instrument, deed or lease
to which any Obligor is a party or by which it is bound, or of the
Charter or By-laws of any Obligor;
the violation of any law, judgment, decree or governmental order, rule
or regulation applicable to any Obligor;
the creation under any agreement, instrument, deed or lease of any Lien
(other than Liens on the Credit Security which secure the Credit
Obligations) upon any of the assets of the Obligors; or
any redemption, retirement or other repurchase obligation of any
Obligor under any Charter, By-law, agreement, instrument, deed or
lease.
No approval, authorization or other action by, or declaration to or
filing with, any governmental or administrative authority or any other
Person is required to be obtained or made by the Obligors in connection
with the execution, delivery and performance of this Consent and
Amendment or the performance of the Amended Credit Agreement, or the
consummation of the transactions contemplated hereby or thereby.
DEFAULTS. Immediately before and after giving effect to the consent set forth in
Section 2 hereof and the amendment set forth in Section 3 hereof, no Default
will exist.
INCORPORATION OF REPRESENTATIONS AND WARRANTIES. The representations and
warranties set forth in Section 7 of the Amended Credit Agreement are true and
correct on the date hereof as if originally made on and as of the date hereof.
COMPLIANCE WITH REGULATIONS. The Obligors are in compliance in all material
respects with all applicable Legal Requirements, including without limitation
the Clinical Laboratory Improvement Amendments of 1988 (CLIA).
CONDITIONS. The effectiveness of this Consent and Amendment shall be subject to
the satisfaction of the following conditions that must be satisfied
contemporaneously or immediately after the Neo Gen Acquisition or this Consent
and Amendment shall terminate:
TRANSACTION DOCUMENTS. Agent shall have received copies of all material
transaction documents related to the Neo Gen Acquisition and they shall be
reasonably satisfactory to Agent.
OTHER DOCUMENTS. Pursuant to Section 6.9.4(g) of the Credit Agreement, Agent
shall have received either (a) a Revolving Note for each Lender and a Joinder
Agreement to the Credit Agreement and each other Credit Document in the form of
Exhibit 6.9.4, each executed by the Corporation and the Partnership; or (b) a
certificate of a Financial Officer of the Company to the effect that a merger
was consummated between the Corporation and the Partnership and an existing
Borrower.
PLEDGE OF STOCK. If the Agent is provided with the documents referenced in
Section 5.2(a) of this Consent and Amendment, the Company and other Guarantors
pledge the stock (but not more than 66% of the voting stock of a Foreign
Subsidiary) of the Corporation.
NON-CONTEMPORANEOUS CONDITIONS. The effectiveness of this Consent and Amendment
shall also be subject to the satisfaction of the following condition, which must
be satisfied within five days of the closing of the Neo Gen Acquisition:
DOCUMENTS REGARDING SECURITY INTEREST. Agent shall have received such financing
statements, mortgages and other documentation as the Agent shall request to
attach a security interest to the assets of Neo Gen Screening and to perfect
such security interest.
FURTHER ASSURANCES. Each of the Obligors will, promptly upon the request of the
Agent from time to time, execute, acknowledge, deliver, file and record all such
instruments and notices, and take all such other action, as the Agent deems
necessary or advisable to carry out the intent and purposes of this Consent and
Amendment.
GENERAL. The Amended Credit Agreement and all of the Credit Documents are each
confirmed as being in full force and effect. This Consent and Amendment, the
Amended Credit Agreement, the Assignment and the other Credit Documents referred
to herein or therein constitute the entire understanding of the parties with
respect to the subject matter hereof and thereof and supersede all prior and
current understandings and agreements, whether written or
2
oral. Each of this Consent and Amendment and the Amended Credit Agreement is a
Credit Document and may be executed in any number of counterparts, which
together shall constitute one instrument, and shall bind and inure to the
benefit of the parties and their respective successors and assigns, including as
such successors and assigns all holders of any Credit Obligation. This Consent
and Amendment shall be governed by and construed in accordance with the laws
(other than the conflict of law rules) of The Commonwealth of Massachusetts.
[THE REMAINDER OF THIS PAGE IS INTENTIONALLY BLANK.]
3
IN WITNESS WHEREOF, each of the undersigned has duly executed this
Consent and Amendment (or caused this Consent and Amendment to be executed on
its behalf by its officer or representative thereunto duly authorized) under
seal as of the date first written above.
PEDIATRIX MEDICAL GROUP, INC. (Florida)
By: /s/ XXXX X. XXXXXX
---------------------------------------------------
Xxxx X. Xxxxxx, Chief Financial Officer
ALASKA NEONATOLOGY ASSOCIATES, INC.
AUGUSTA NEONATOLOGY ASSOCIATES, P.C.
DES MOINES PERINATAL CENTER, P.C.
FOOTHILL MEDICAL GROUP, INC.
FORT WORTH NEONATAL ASSOCIATES, P.A.
OBSTETRIX MEDICAL GROUP OF CALIFORNIA, A PROFESSIONAL
CORPORATION
MAGELLA HEALTHCARE GROUP, X.X.
XXXXXXX MEDICAL ASSOCIATES, P.A.
MAGELLA MEDICAL ASSOCIATES OF GEORGIA, P.C.
MAGELLA MEDICAL ASSOCIATES MIDWEST, P.C.
MAGELLA MEDICAL GROUP, INC. (d/b/a MAGELLA
MEDICAL GROUP, A MEDICAL CORPORATION)
MAGELLA NEVADA, LLC
MAGELLA TEXAS, LLC
XXXXXX X. XXXXXXX, M.D. PROF. CORP. d/b/a OBSTETRIX
MEDICAL GROUP OF NEVADA, LTD.
MOUNTAIN STATES NEONATOLOGY, INC.
NEONATAL AND PEDIATRIC INTENSIVE CARE
MEDICAL GROUP, INC.
NEONATOLOGY ASSOCIATES, P.A.
NEONATOLOGY-CARDIOLOGY ASSOCIATES, P.A.
NEWBORN SPECIALISTS, P.C.
OBSTETRIX MEDICAL GROUP OF COLORADO, P.C.
OBSTETRIX MEDICAL GROUP OF KANSAS AND
MISSOURI, P.A.
OBSTETRIX MEDICAL GROUP OF TEXAS, P.A.
OZARK NEONATAL ASSOCIATES, INC.
By: /s/ XXXX X. XXXXXX
---------------------------------------------------
Xxxx X. Xxxxxx, Attorney-in-Fact
4
PEDIATRIX MEDICAL GROUP OF ARKANSAS, P.A.
PEDIATRIX MEDICAL GROUP OF CALIFORNIA, A
PROFESSIONAL CORPORATION
PEDIATRIX MEDICAL GROUP OF COLORADO, P.C.
PEDIATRIX MEDICAL GROUP OF GEORGIA, P.C.
PEDIATRIX MEDICAL GROUP OF INDIANA, P.C.
PEDIATRIX MEDICAL GROUP OF KANSAS, P.A.
PEDIATRIX MEDICAL GROUP OF MISSOURI, P.C.
PEDIATRIX MEDICAL GROUP OF OKLAHOMA, P.C.
PEDIATRIX MEDICAL GROUP OF PENNSYLVANIA, P.C.
PEDIATRIX MEDICAL GROUP OF PUERTO RICO, P.S.C.
PEDIATRIX MEDICAL GROUP OF TEXAS, P.A.
PEDIATRIX MEDICAL GROUP NEONATOLOGY AND
PEDIATRIC INTENSIVE CARE SPECIALISTS
OF NEW YORK, P.C.
PEDIATRIX MEDICAL GROUP
PEDIATRIX OF MARYLAND, P.A.
PERINATAL PEDIATRICS, P.A.
PERNOLL MEDICAL GROUP OF NEVADA, LTD.
d/b/a PEDIATRIX MEDICAL GROUP OF NEVADA
SAVANNAH NEONATOLOGY, INC.
ST. XXXXXX NEONATOLOGY CONSULTANTS, P.A.
TEXAS MATERNAL FETAL MEDICINE, P.A.
By: /s/ XXXX X. XXXXXX
---------------------------------------------------
Xxxx X. Xxxxxx, Attorney-in-Fact
PEDIATRIX MEDICAL GROUP OF OHIO CORP.
By: /s/ XXXX X. XXXXXX
---------------------------------------------------
Xxxx X. Xxxxxx, Secretary
5
ASSOCIATES IN NEONATOLOGY, INC.
BNA ACQUISITION COMPANY, INC.
CENTRAL OKLAHOMA NEONATOLOGY
ASSOCIATES, INC.
FLORIDA REGIONAL NEONATAL ASSOCIATES, P.A.
GNPA ACQUISITION COMPANY, INC.
MAGELLA HEALTHCARE CORPORATION
MNPC ACQUISITION COMPANY, INC.
NACF ACQUISITION COMPANY, INC.
NEONATAL SPECIALISTS, LTD.
NSPA ACQUISITION COMPANY, INC.
OBSTETRIX MEDICAL GROUP OF ARIZONA, P.C.
OBSTETRIX MEDICAL GROUP OF DELAWARE, INC.
OBSTETRIX MEDICAL GROUP OF PENNSYLVANIA, P.C.
OBSTETRIX MEDICAL GROUP OF PHOENIX, P.C.
OBSTETRIX MEDICAL GROUP OF
WASHINGTON, INC., P.S.
OBSTETRIX MEDICAL GROUP, INC.
PALM BEACH NEO ACQUISITIONS, INC.
PASCV ACQUISITION COMPANY, INC.
PEDIATRIX MEDICAL GROUP OF DELAWARE, INC.
PEDIATRIX MEDICAL GROUP OF FLORIDA, INC.
PEDIATRIX MEDICAL GROUP OF NEW MEXICO, P.C.
PEDIATRIX MEDICAL GROUP OF SOUTH CAROLINA, P.A.
PEDIATRIX MEDICAL GROUP OF TENNESSEE, P.C.
PEDIATRIX MEDICAL GROUP OF WASHINGTON, INC., P.S.
PEDIATRIX MEDICAL GROUP, INC. (Utah)
PEDIATRIX MEDICAL GROUP, P.A.
PEDIATRIX MEDICAL GROUP, P.C. (Virginia)
PEDIATRIX MEDICAL GROUP, P.C. (West Virginia)
PMG ACQUISITION CORP.
PNA ACQUISITION CO., INC.
RPNA ACQUISITION COMPANY, INC.
XXXXX XXXXXXXXXXX XX.
XXXX ACQUISITION COMPANY, INC.
By: /s/ XXXX X. XXXXXX
---------------------------------------------------
Xxxx X. Xxxxxx, Treasurer
6
FLEET NATIONAL BANK
By: /s/ XXXXXX XXXXXXXXXXXXX
---------------------------------------
Xxxxxx Xxxxxxxxxxxxx, Managing Director
7
U.S. BANK NATIONAL ASSOCIATION
By: /s/ XXXXXX X. XXXXXXX
---------------------------------------------------
Xxxxxx X. Xxxxxxx, Senior Vice President
8
HSBC BANK USA
By: /s/ XXXX X. XXXX
---------------------------------------------------
Xxxx X. Xxxx, Senior Vice President
9
UBS AG, STAMFORD BRANCH
By: /s/ XXXXXXX X. SAINT
---------------------------------------------------
Xxxxxxx X. Saint, Associate Director
Banking Products Services, US
By: /s/ XXXXX XXXXXXX
---------------------------------------------------
Xxxxx Xxxxxxx, Associate Director
Banking Products Services, US
10
THE INTERNATIONAL BANK OF MIAMI, N.A.
By: /s/ XXXXXXX XXXXXXX
---------------------------------------------------
Xxxxxxx Xxxxxxx, Vice President
By: /s/ XXXXX XXXXXXX
---------------------------------------------------
Xxxxx Xxxxxxx, Senior Vice President
11
